Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             154 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 2014
 8 S2 p. S439-S444
6 p.
 artikel
2 Copyright 2014
 8 S2 p. ii-
1 p.
 artikel
3 Editorial Board 2014
 8 S2 p. iii-
1 p.
 artikel
4 Front matter 2014
 8 S2 p. i-
1 p.
 artikel
5 O-33: Aberrant serological response, male predominance, and higher rate of perianal lesions in pediatric newly-onset Crohn’s disease with primary sclerosing cholangitis Sladek, M.
 2014
 8 S2 p. S437-
1 p.
 artikel
6 O-26: A learning health system to transform the health, care and cost of IBD Colletti, R.B.
 2014
 8 S2 p. S425-S426
2 p.
 artikel
7 O-31: Biologicals and biosimilars: Is similar the same? Declerck, P.J.
 2014
 8 S2 p. S427-
1 p.
 artikel
8 O-09: Differences in adults and pediatrics, does it matter? van Limbergen, J.E.
 2014
 8 S2 p. S399-
1 p.
 artikel
9 O-23: Effectiveness of nutritional and anti-TNF therapy in North American children with active Crohn’s disease Lee, D.Y.
 2014
 8 S2 p. S420-
1 p.
 artikel
10 O-06: Epigenetic regulation of immune tolerance in intestinal epithelium Mokry, M.
 2014
 8 S2 p. S394-
1 p.
 artikel
11 O-13: Fecal markers in IBD: ready for primetime! van Rheenen, P.F.
 2014
 8 S2 p. S405-
1 p.
 artikel
12 O-21: Growth retardation: pathogenesis and therapeutic interventions Kolacek, S.
 2014
 8 S2 p. S419-
1 p.
 artikel
13 O-32: How the ECCO-ESPGHAN Consensus Guidelines guide the management of paediatric Crohn’s disease Ruemmele, F.
 2014
 8 S2 p. S437-
1 p.
 artikel
14 O-01: IL-10 receptor dependent signals regulate the generation and function of anti-inflammatory macrophages in mice and humans Snapper, S.B.
 2014
 8 S2 p. S393-
1 p.
 artikel
15 O-15: ImproveCareNow (ICN) as a quality improvement (QI) tool in a paediatric inflammatory bowel disease (pIBD) Chadokufa, S.
 2014
 8 S2 p. S405-
1 p.
 artikel
16 O-10: Increase of inflammatory bowel disease incidence in teenagers in a prospective population-based study during a 21-year period (1998–2008) Ghione, S.
 2014
 8 S2 p. S399-
1 p.
 artikel
17 O-19: Is diet the environmental factor that is responsible for IBD? Levine, A.
 2014
 8 S2 p. S419-
1 p.
 artikel
18 O-30: Long-term efficacy of adalimumab in paediatric patients with Crohn’s disease Faubion, W.
 2014
 8 S2 p. S427-
1 p.
 artikel
19 O-25: Long-term function and quality of life after ileal pouch-anal anastomosis; better in younger patients? Bakia, J.M.
 2014
 8 S2 p. S424-
1 p.
 artikel
20 O-05: Metagenomic analysis of the gut microbiome during a course of Exclusive Enteral Nutrition (EEN) provides novel insights on mechanism of EEN action Gerasimidis, K.
 2014
 8 S2 p. S393-S394
2 p.
 artikel
21 O-16: MRE cannot replace gastroscopy (EGD) in assessing the upper gastrointestinal tract in pediatric Crohn’s disease (CD): results from the ImageKids study Church, P.C.
 2014
 8 S2 p. S406-
1 p.
 artikel
22 O-28: New biologicals, mechanism of action Cucchiara, S.
 2014
 8 S2 p. S426-
1 p.
 artikel
23 O-29: Oral versus subcutaneous methotrexate (MTX) in pediatric Crohn’s disease (CD): a multicenter propensity score (PS) study Turner, D.
 2014
 8 S2 p. S426-
1 p.
 artikel
24 O-22: Partial enteral nutrition with a Crohn’s disease exclusion diet (CDED) is effective for induction of remission in children and young adults with mild to moderate Crohn’s disease Sigall Boneh, R.
 2014
 8 S2 p. S419-
1 p.
 artikel
25 O-11: Real world outcomes of contemporary treatments in children with Crohn’s disease: observations from the pediatric IBD collaborative research group registry Markowitz, J.
 2014
 8 S2 p. S400-
1 p.
 artikel
26 O-08: Registries from North America: What have we learned? Hyams, J.S.
 2014
 8 S2 p. S399-
1 p.
 artikel
27 O-27: Safety of immunosuppressives and biologicals Hyams, J.S.
 2014
 8 S2 p. S426-
1 p.
 artikel
28 O-04: Secretory leukocyte protease inhibitor (SLPI) is a potent regulator of microbial induced monocyte activation and intestinal inflammation Menckeberg, C.L.
 2014
 8 S2 p. S393-
1 p.
 artikel
29 O-17: Study of abnormal liver function tests at diagnosis of paediatric inflammatory bowel disease (PIBD) in a large cohort in southern England van der Feen, C.
 2014
 8 S2 p. S406-
1 p.
 artikel
30 O-18: Tandem talk: MRI shows the future Greer, M.L.
 2014
 8 S2 p. S406-
1 p.
 artikel
31 O-12: Ten years of paediatric inflammatory bowel disease incidence in the north of Scotland Jagger, F.A.
 2014
 8 S2 p. S400-
1 p.
 artikel
32 O-34: The UK inflammatory bowel disease (IBD) audit: 3 audits, 700 paediatric ulcerative colitis (UC) inpatients, many clinical messages Russell, R.K.
 2014
 8 S2 p. S437-
1 p.
 artikel
33 O-24: 10 year experience of surgery for 69 children with Crohn’s disease: indications, complications and outcome Stanton, M.P.
 2014
 8 S2 p. S423-S424
2 p.
 artikel
34 P-052: Accumulation of intra-abdominal adipose tissue in pediatric Crohn’s disease Frivolt, K.
 2014
 8 S2 p. S412-
1 p.
 artikel
35 P-032: Achieving remission in paediatric inflammatory bowel disease (pIBD): data on mono- vs. combination therapy using the ImproveCareNow (ICN) data base Papadopoulos, M.
 2014
 8 S2 p. S404-S405
2 p.
 artikel
36 P-087: Adalimumab as first-line anti-TNF treatment in pediatric Crohn’s disease Martín-de-Carpi, J.
 2014
 8 S2 p. S427-
1 p.
 artikel
37 P-116: Adalimumab in refractory paediatric ulcerative colitis Volonaki, E.
 2014
 8 S2 p. S435-S436
2 p.
 artikel
38 P-057A: Detecting inflammation in pediatric inflammatory bowel disease: the role of fecal calprotectin and its impact on management Foster, A.J.
 2014
 8 S2 p. S414-
1 p.
 artikel
39 P-004: Altered Pregnane X Receptor (PXR) expression in children with active Crohn’s disease Shakhnovich, V.
 2014
 8 S2 p. S395-
1 p.
 artikel
40 P-105: Anti-TNF for the prevention of postoperative recurrence in pediatric Crohn’s disease Martín-de-Carpi, J.
 2014
 8 S2 p. S432-S433
2 p.
 artikel
41 P-057: A nurse-led tertiary adolescent IBD clinic: 12 month trial and exploration of patient satisfaction Whitley, L.
 2014
 8 S2 p. S413-
1 p.
 artikel
42 P-058: A nurse-led tertiary paediatric IBD (pIBD) telephone service: results of service restructure Chadokufa, S.
 2014
 8 S2 p. S414-
1 p.
 artikel
43 P-009A: Osteoprotegerin: a novel alarmin in colonic epithelial cells? Ramanarasimhaiah, R.
 2014
 8 S2 p. S396-S397
2 p.
 artikel
44 P-045A: Prediction of relapse using consecutive measurements of fecal calprotectin in pediatric Crohn’s disease patients Foster, A.J.
 2014
 8 S2 p. S410-
1 p.
 artikel
45 P-039: Assessing phenotype and disease prognosis in early onset IBD. Retrospective data from 2 tertiary centres in the United Kingdom and Italy Gasparetto, M.
 2014
 8 S2 p. S408-
1 p.
 artikel
46 P-109: Autologous haematopoietic stem cell transplantation in two paediatric patients with refractory Crohn’s disease Boros, B.K.
 2014
 8 S2 p. S433-S434
2 p.
 artikel
47 P-062: Azathioprine and lymphocyte count in paediatric inflammatory bowel disease Volonaki, E.
 2014
 8 S2 p. S415-
1 p.
 artikel
48 P-098: Azathioprine dose and pharmacokinetics in early-onset pediatric inflammatory bowel disease Stocco, G.
 2014
 8 S2 p. S430-S431
2 p.
 artikel
49 P-102: Bioavailability and tolerance of high doses vitamin D in children with newly diagnosed Crohn’s disease Jantchou, P.
 2014
 8 S2 p. S432-
1 p.
 artikel
50 P-110: Bone marrow toxicity secondary to primary infection by Epstein–Barr virus in a patient with Crohn’s disease treated with thiopurines Martín-de-Carpi, J.
 2014
 8 S2 p. S434-
1 p.
 artikel
51 P-056: Buccal epithelial cell chemokine release as a biomarker for clinical response to therapy in inflammatory bowel disease Winter, D.A.
 2014
 8 S2 p. S413-
1 p.
 artikel
52 P-002: Butyrate producing microbes at the luminal mucosal interface are reduced in children newly diagnosed with Crohn’s disease Mack, D.R.
 2014
 8 S2 p. S394-S395
2 p.
 artikel
53 P-051: Changes in selective lipids during treatment-induced remission of active pediatric IBD Brahmbhatt, V.
 2014
 8 S2 p. S412-
1 p.
 artikel
54 P-001: Characteristics of specific microRNA expression in colonic mucosa in pediatric patients with Crohn’s disease Béres, N.J.
 2014
 8 S2 p. S394-
1 p.
 artikel
55 P-018: Clinical presentation, therapeutic approach and disease course of pediatric ulcerative colitis in a referral center Pina, M.
 2014
 8 S2 p. S401-
1 p.
 artikel
56 P-013: Colitis in the graft of children treated with intestinal transplantation is associated with NOD2 mutations Veereman, G.
 2014
 8 S2 p. S398-
1 p.
 artikel
57 P-113: Comparative efficacy of mesalamine and azathioprine in pediatric ulcerative colitis after steroid-induced remission at diagnosis Martín-de-Carpi, J.
 2014
 8 S2 p. S434-S435
2 p.
 artikel
58 P-031: Comparing prospective, multicenter registries on pediatric IBD from different continents; results from the Pediatric IBD Collaborative Research Group Registry and the EUROKIDS registry Winter, D.A.
 2014
 8 S2 p. S404-
1 p.
 artikel
59 P-079: Comparison of quality of life among children treated with nutritional and anti-TNF therapies for active Crohn’s disease in North America Otley, A.R.
 2014
 8 S2 p. S423-
1 p.
 artikel
60 P-067: C reactive protein as a predictor of response to infliximab in pediatric Crohn’s disease Al-Sahafi, A.
 2014
 8 S2 p. S416-
1 p.
 artikel
61 P-095: Crohn’s disease localization does not contribute to response for induction therapy with infliximab in children Dadalski, M.
 2014
 8 S2 p. S430-
1 p.
 artikel
62 P-048: Cut-off value of fecal calprotectin in pediatric patients with inflammatory bowel disease Veres, G.
 2014
 8 S2 p. S411-
1 p.
 artikel
63 P-046: Damage and inflammatory activity in pediatric Crohn’s disease (CD) based on radiologist and gastroenterologist physician global assessment Focht, G.
 2014
 8 S2 p. S410-
1 p.
 artikel
64 P-033: Data on surgery in paediatric IBD (pIBD) over a 4 year period using the ImproveCareNow (ICN) collaboration data base Acton, N.
 2014
 8 S2 p. S405-
1 p.
 artikel
65 P-003: Detection of bacterial and host proteins from a single colonic biopsy sample by a new mass spectrometry-based assay in pediatric ulcerative colitis Kalliomäki, M.
 2014
 8 S2 p. S395-
1 p.
 artikel
66 P-042: Diagnostic delay in pediatric inflammatory bowel disease in Spain Jimenez, S.
 2014
 8 S2 p. S409-
1 p.
 artikel
67 P-034: Diagnostic non-invasive tests for inflammatory bowel disease in children, a systematic review and meta-analysis Holtman, G.A.
 2014
 8 S2 p. S406-S407
2 p.
 artikel
68 P-011: Differential induction of T cell tolerance in the small and large intestine Veenbergen, S.
 2014
 8 S2 p. S397-
1 p.
 artikel
69 P-068: Disease-related knowledge in New Zealand children with inflammatory bowel disease (IBD) and their parents Day, A.S.
 2014
 8 S2 p. S416-S417
2 p.
 artikel
70 P-037: Does inflammatory bowel disease (Unclassified) evolve into Crohn’s disease or ulcerative colitis? Paul, S.P.
 2014
 8 S2 p. S407-
1 p.
 artikel
71 P-078: Does inflammatory status correlates with growth evolution in children with IBD? Ezri, J.
 2014
 8 S2 p. S422-
1 p.
 artikel
72 P-104: Duration of remission in children with Crohn’s disease treated initially with corticosteroids or exclusive enteral nutrition Hradsky, O.
 2014
 8 S2 p. S432-
1 p.
 artikel
73 P-107: Effect of exclusive enteral nutrition on the course of CD and intestinal microbiota Pigneur, B.
 2014
 8 S2 p. S433-
1 p.
 artikel
74 P-007: Effect of Th-1 and Th-17 prototype cytokines on endothelial microparticle formation in vitro: implication for vascular dysfunction in inflammatory bowel disease Bonner, J.O.E.
 2014
 8 S2 p. S396-
1 p.
 artikel
75 P-094: Efficacy of partial elemental nutrition as a maintenance therapy for pediatric Crohn’s disease Sekine, K.
 2014
 8 S2 p. S429-
1 p.
 artikel
76 P-035: Elevated faecal calprotectin does not differentiate between IBD and a juvenile polyp Wolters, V.M.
 2014
 8 S2 p. S407-
1 p.
 artikel
77 P-059: Endoscopy in IBD women is safe in each trimester of pregnancy DeLima, A.
 2014
 8 S2 p. S414-
1 p.
 artikel
78 P-084: Eosinophilic gastroenteropathy – from diet to colectomy Karoliny, A.
 2014
 8 S2 p. S425-
1 p.
 artikel
79 P-093: Exclusive enteral nutrition and infliximab for treatment of ulcerative colitis with extraintestinal manifestation Pappas, A.
 2014
 8 S2 p. S429-
1 p.
 artikel
80 P-073: Exclusive enteral nutrition in the treatment of children with Crohn’s disease in the Netherlands: a questionnaire survey amongst dietitians Dijkstra, T.
 2014
 8 S2 p. S421-
1 p.
 artikel
81 P-028: Extraintestinal manifestations in Bulgarian pediatric patients with inflammatory bowel disease – a single center experience Shentova, R.
 2014
 8 S2 p. S403-S404
2 p.
 artikel
82 P-008: Fecal gas analysis by electronic nose: a novel, non-invasive technique for assessment of active and quiescent pediatric inflammatory bowel disease De Meij, T.G.J.
 2014
 8 S2 p. S396-
1 p.
 artikel
83 P-074: Food practices and use of complementary & alternative medicine (CAM) in pediatric inflammatory bowel disease (IBD) patients in Singapore Ong, F.
 2014
 8 S2 p. S421-
1 p.
 artikel
84 P-103: Granulocyte-monocyte apheresis for remission in newly diagnosed ulcerative colitis Rolandsdotter, J.
 2014
 8 S2 p. S432-
1 p.
 artikel
85 P-072: Growth improvement in adalimumab-treated paediatric patients with Crohn’s disease: data from IMAgINE 1 Walters, T.
 2014
 8 S2 p. S420-S421
2 p.
 artikel
86 P-077: Growth pattern in pediatric Crohn’s disease is related to inflammatory status and not to cumulative duration of steroid therapy Ley, D.
 2014
 8 S2 p. S422-
1 p.
 artikel
87 P-043: Health related quality of life in paediatric inflammatory bowel disease in a Southeast Asian population Liwanag, M.J.
 2014
 8 S2 p. S409-
1 p.
 artikel
88 P-070: Height at the time of diagnosis of inflammatory bowel disease in Japanese children: an analysis of Japanese national registry data Ishige, T.
 2014
 8 S2 p. S420-
1 p.
 artikel
89 P-015: Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor Menckeberg, C.L.
 2014
 8 S2 p. S398-
1 p.
 artikel
90 P-075: Hypovitaminosis D in children with IBD assessed for bone metabolism Senecic-Cala, I.
 2014
 8 S2 p. S421-
1 p.
 artikel
91 P-050: Idiopathic thrombocytopenic purpura associated to pediatric Crohn’s disease; diagnostic and therapeutic implications Martín-de-Carpi, J.
 2014
 8 S2 p. S411-
1 p.
 artikel
92 P-100: Immune thrombocytopenia and pediatric ulcerative colitis management: a role for anti-TNF alpha treatment? Valério de Azevedo, S.
 2014
 8 S2 p. S431-
1 p.
 artikel
93 P-016: Impact of Campylobacter concisus on paediatric inflammatory bowel disease Mcmullen, L.
 2014
 8 S2 p. S398-S399
2 p.
 artikel
94 P-097: Impact of concomitant immunosuppressant use on adalimumab efficacy in children with moderately to severely active Crohn’s disease: results from IMAgINE 1 Hyams, J.S.
 2014
 8 S2 p. S430-
1 p.
 artikel
95 P-023: Impact of socio-economic position on incidence of inflammatory bowel disease in children Paul, S.P.
 2014
 8 S2 p. S402-
1 p.
 artikel
96 P-064: Improvement of patient’s disease activity in paediatric inflammatory disease (pIBD) after adoption of ImproveCareNow (ICN) quality improvement (QI) tool Huggett, B.
 2014
 8 S2 p. S415-S416
2 p.
 artikel
97 P-014: Increased expression of IL-21 and co-localization with IFN gamma in inflammatory lesions of pediatric Crohn’s disease Costes, L.M.M.
 2014
 8 S2 p. S398-
1 p.
 artikel
98 P-029: Increasing incidence of paediatric IBD in New South Wales Australia, 1968–2013 Lee, C.H.
 2014
 8 S2 p. S404-
1 p.
 artikel
99 P-026: Inflammatory bowel disease in Romanian children – the experience of a single center Lesanu, G.
 2014
 8 S2 p. S403-
1 p.
 artikel
100 P-053: Infliximab trough levels are associated with disease activity in pediatric inflammatory bowel disease Hoekman, D.R.
 2014
 8 S2 p. S412-
1 p.
 artikel
101 P-010: Interleukin-10 inhibits human IFNγ-secreting effector T cells indirectly by controlling antigen-presenting cell function Veenbergen, S.
 2014
 8 S2 p. S397-
1 p.
 artikel
102 P-025: Is it Crohn’s disease? Diagnostic errors in a young child Belei, O.
 2014
 8 S2 p. S402-S403
2 p.
 artikel
103 P-020: Japan pediatric inflammatory bowel disease registry just embarked Arai, K.
 2014
 8 S2 p. S401-
1 p.
 artikel
104 P-111: Maintenance of remission with partial enteral nutrition therapy in pediatric Crohn’s disease: a retrospective study Shaoul, R.
 2014
 8 S2 p. S434-
1 p.
 artikel
105 P-005: Mechanism of action of potential live biotherapeutics for the treatment of inflammatory bowel disease Mulder, I.E.
 2014
 8 S2 p. S395-
1 p.
 artikel
106 P-017: Methotrexate after thiopurine therapy in children with Crohn’s disease: a multicenter cohort study Haisma, S.M.
 2014
 8 S2 p. S400-S401
2 p.
 artikel
107 P-117: Methotrexate as a treatment option in pediatric Crohn’s disease Hojsak, I.
 2014
 8 S2 p. S436-
1 p.
 artikel
108 P-080: Paris location does not influence the clinical efficacy of exclusive enteral nutrition therapy in pediatric patients with Crohn’s disease: 20 years single centre experience Otley, A.R.
 2014
 8 S2 p. S423-
1 p.
 artikel
109 P-076: Persistence of growth retardation in pediatric Crohn’s disease Amil Dias, J.
 2014
 8 S2 p. S422-
1 p.
 artikel
110 P-040: Personalized infliximab treatment of adolescents with inflammatory bowel disease Carlsen, K.
 2014
 8 S2 p. S408-
1 p.
 artikel
111 P-021: Phenotype of paediatric IBD in a Southeast Asian population Liwanag, M.J.
 2014
 8 S2 p. S401-S402
2 p.
 artikel
112 P-054: Physical activity in children with inflammatory bowel disease compared to healthy controls Ezri, J.
 2014
 8 S2 p. S412-S413
2 p.
 artikel
113 P-088: Posterior reversible encephalopathy syndrome (PRES) as a side effect of biological treatment of IBD in children Karaskova, E.
 2014
 8 S2 p. S427-S428
2 p.
 artikel
114 P-060: Preconception care in IBD women leads to less disease relapses during pregnancy DeLima, A.
 2014
 8 S2 p. S414-S415
2 p.
 artikel
115 P-071: Prevalence of anaemia in pediatric inflammatory bowel disease at diagnosis and its course during the follow-up Pina, M.
 2014
 8 S2 p. S420-
1 p.
 artikel
116 P-012: Probiotic bacteria enhance antigen sampling and processing by dendritic cells in pediatric IBD Strisciuglio, C.
 2014
 8 S2 p. S397-S398
2 p.
 artikel
117 P-061: Quality of life in children with ulcerative colitis and Crohn’s disease in Greece Chouliaras, G.
 2014
 8 S2 p. S415-
1 p.
 artikel
118 P-089: RAC1 polymorphisms and thiopurine efficacy in children with inflammatory bowel disease Lev-Tzion, R.
 2014
 8 S2 p. S428-
1 p.
 artikel
119 P-096: Rate of and response to dose escalation in paediatric patients with Crohn’s disease from IMAgINE 1 Dubinsky, M.
 2014
 8 S2 p. S430-
1 p.
 artikel
120 P-036: Recognize the clinical picture: chronic recurrent multifocal osteomyelitis (CRMO) associated with Crohn’s disease (CD): a case report Van Biervliet, M.M.
 2014
 8 S2 p. S407-
1 p.
 artikel
121 P-049: Reproducibility of serologic antibody activity at diagnosis and after treatment in pediatric ulcerative colitis and Crohn’s disease Olbjørn, C.
 2014
 8 S2 p. S411-
1 p.
 artikel
122 P-085: Resolution of factor XI (FXI) deficiency in refractory ulcerative colitis (UC) after surgery: a case report Angelakopoulou, A.
 2014
 8 S2 p. S425-
1 p.
 artikel
123 P-114: Response to exclusive enteral nutrition (EEN) in adolescent patients with newly diagnosed Crohn’s disease (CD) Keetarut, K.
 2014
 8 S2 p. S435-
1 p.
 artikel
124 P-024: Rising incidence and increasing severity of very early onset IBD in Ireland Wylde, R.
 2014
 8 S2 p. S402-
1 p.
 artikel
125 P-082: Segmental distribution in refractory ulcerative colitis: a histological evaluation in pediatric and adult patients who underwent proctocolectomy Uchida, K.
 2014
 8 S2 p. S424-
1 p.
 artikel
126 P-065: Serum hepcidin in pediatric inflammatory bowel disease Martinelli, M.
 2014
 8 S2 p. S416-
1 p.
 artikel
127 P-019: Short term clinical course in pediatric IBD based on a nationwide, prospective Hungarian pediatric IBD registry (HUPIR) Müller, K.E.
 2014
 8 S2 p. S401-
1 p.
 artikel
128 P-099: Single center experience with infliximab in Japanese children with ulcerative colitis Shimizu, H.
 2014
 8 S2 p. S431-
1 p.
 artikel
129 P-101: Steroids may reduce the benefit of exclusive enteral diet in Crohn’s disease Amil Dias, J.
 2014
 8 S2 p. S431-S432
2 p.
 artikel
130 P-108: Successful mercaptopurine usage following azathioprine intolerance in paediatric IBD: a regional cohort study Merrick, V.
 2014
 8 S2 p. S433-
1 p.
 artikel
131 P-083: Surgery in pediatric IBD experience of the Transylvanian Reference Tertiary Centre (Romania), 1998–2014 Serban, D.E.
 2014
 8 S2 p. S424-S425
2 p.
 artikel
132 P-119: Tacrolimus use in paediatric inflammatory bowel disease Chan, J.
 2014
 8 S2 p. S436-
1 p.
 artikel
133 P-112: The association between drug levels, anti-drug antibodies, and therapeutic response during infliximab therapy in pediatric Crohn’s disease Stein, R.E.
 2014
 8 S2 p. S434-
1 p.
 artikel
134 P-066: The association between perceived relational support and health related quality of life in adolescents with inflammatory bowel disease Hummel, T.Z.
 2014
 8 S2 p. S416-
1 p.
 artikel
135 P-106: The clinical relevance of tacrolimus for ulcerative colitis in children: a national survey of the treatments for pediatric inflammatory bowel disease in Japan Yanagi, T.
 2014
 8 S2 p. S433-
1 p.
 artikel
136 P-092: The course of anaemia in children with Crohn’s disease included in a prospective registry Van Biervliet, M.M.
 2014
 8 S2 p. S429-
1 p.
 artikel
137 P-006: The effect of exclusive enteral nutrition on the microbiota of newly diagnosed pediatric Crohn’s disease patients Kaakoush, N.O.
 2014
 8 S2 p. S395-S396
2 p.
 artikel
138 P-091: The efficacy of infliximab in pediatric patients with steroid-dependent intestinal Beh¸cet’s disease: a single center experience in Japan Hagiwara, S.
 2014
 8 S2 p. S428-S429
2 p.
 artikel
139 P-009: The interaction of bacteria and the ileal mucosa: role of pathobionts and mucus secretion in pediatric inflammatory bowel diseases Alipour, M.
 2014
 8 S2 p. S396-
1 p.
 artikel
140 P-081: The major pathway by which polymeric formula reduces intestinal inflammation in Crohn’s disease patients a microarray-based analysis Nahidi, L.
 2014
 8 S2 p. S423-
1 p.
 artikel
141 P-055: The natural history of pediatric IBD according to the Paris classification van Limbergen, J.E.
 2014
 8 S2 p. S413-
1 p.
 artikel
142 P-047: The safety and effectiveness of carbon dioxide insufflation during colonoscopy in sedated pediatric patients with inflammatory bowel disease Abe, N.
 2014
 8 S2 p. S410-S411
2 p.
 artikel
143 P-045: The usefulness of fecal calprotectin in monitoring inflammatory activity among children with Crohn’s disease and ulcerative colitis Belei, O.
 2014
 8 S2 p. S410-
1 p.
 artikel
144 P-044: Thioguanine metabolite testing in a South East Asian cohort of children with inflammatory bowel disease Huang, J.
 2014
 8 S2 p. S409-S410
2 p.
 artikel
145 P-115: Thiopurine metabolite (TM) monitoring in adolescent IBD (aIBD): Poor adherence is common Kiparissi, F.
 2014
 8 S2 p. S435-
1 p.
 artikel
146 P-063: Thiopurine metabolite (TM) monitoring in paediatric IBD (PIBD): revolution of clinical practice Angelakopoulou, A.
 2014
 8 S2 p. S415-
1 p.
 artikel
147 P-086: Total colectomy in pediatric ulcerative colitis: a cohort study from a tertiary center in Greece Dimakou, K.
 2014
 8 S2 p. S425-
1 p.
 artikel
148 P-030: Triple increase in incidence of inflammatory bowel disease under 5 years in a 6 year follow-up based on a nationwide, prospective incidence cohort (HUPIR) Tárnok, A.
 2014
 8 S2 p. S404-
1 p.
 artikel
149 P-038: Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases Aomatsu, T.
 2014
 8 S2 p. S408-
1 p.
 artikel
150 P-118: Use of complementary and alternative medicines among children with inflammatory bowel disease Carette-Lherbier, S.
 2014
 8 S2 p. S436-
1 p.
 artikel
151 P-090: Use of thiopurines in Swiss pediatric IBD patients Ezri, J.
 2014
 8 S2 p. S428-
1 p.
 artikel
152 P-041: Variation in correlation between consecutive measured disease score and F-calprotectin in paediatric inflammatory bowel disease Carlsen, K.
 2014
 8 S2 p. S408-S409
2 p.
 artikel
153 P-022: What is the difference between early-onset pediatric ulcerative colitis and late-onset pediatric ulcerative colitis? A single center experience in Japan Nambu, R.
 2014
 8 S2 p. S402-
1 p.
 artikel
154 P-027: 3-year follow-up of pediatric patients with inflammatory bowel diseases in Hungary: first results from a nationwide pediatric registry (HUPIR) Cseh, A.
 2014
 8 S2 p. S403-
1 p.
 artikel
                             154 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring